Catalyst Wire Dossier Catalyst Wire Dossier

Jentadueto

linagliptin/metformin · Boehringer Ingelheim International GmbH
Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for Jentadueto, covering 2012-01-30 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

See pricing